SCHEMBL5146741

SCHEMBL5146741

CCN(CC)c1ccc(C2CCCC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.50
ALDH1A1 P00352 5/20 0.49
GFER P55789 2/20 0.47
PSMD14 O00487 1/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
RECQL P46063 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALDH3A1 P30838 1/20 0.44
ALDH1A3 P47895 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 2/20 0.43
CNR2 P34972 6/20 0.41
CNR1 P21554 3/20 0.41
NOS3 P29474 2/20 0.41
NOS1 P29475 2/20 0.41
NOS2 P35228 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5144890 0.98 RAB9A (0.49) RAB9AALDH1A1GFERPSMD14CYP3A4
SCHEMBL5146739 0.96 ALDH1A1 (0.48) RAB9AALDH1A1GFERPSMD14CYP3A4
SCHEMBL5146728 0.92 ALDH1A1 (0.50) RAB9AALDH1A1GFERPSMD14CYP3A4
SCHEMBL11302817 0.81 RAB9A (0.40) RAB9AALDH1A1GFERMEN1KMT2A
SCHEMBL22313470 0.81 ALDH1A1 (0.46) ALDH1A1TDP1KMT2AKDM4ENOS3
SCHEMBL23691297 0.79 HTT (0.43) ALDH1A1TDP1L3MBTL1KMT2AKDM4E
SCHEMBL8121053 0.77 SLC18A3 (0.60) ALDH1A1CYP3A4TSHRMAPK1RECQL
SCHEMBL23710686 0.76 ALDH1A1 (0.42) ALDH1A1KDM4ENOS3NOS1NOS2
SCHEMBL10052123 0.75 SLC18A3 (0.58) ALDH1A1TSHRTDP1L3MBTL1KMT2A
SCHEMBL20210323 0.75 SLC18A3 (0.46) ALDH1A1TDP1KMT2ANOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299072-A1 KV1.5 POTASSIUM CHANNEL INHIBITORS WYETH (US) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299072-A1 KV1.5 POTASSIUM CHANNEL INHIBITORS KCNA5, KCNH1, KCNK5 RAB9A 2177/4885ALDH1A1 888/4885GFER 2832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.